Increased oxidative/nitrosative stress markers measured non- invasively in patients with high 2,3,7,8-tetrachloro-dibenzo-p-dioxin plasma level

Neuroendocrinology Letters

Volumn 32, Issue SUPPL. 1, 2011, Pages 71-76

  Pelclova, Daniela ^a   Navratil, Tomas ^b   Fenclova, Zdenka ^a   Vlckova, Stepanka ^a   Kupka, Karel ^a   Urban, Pavel ^a   Ridzon, Petr ^a   Zikan, Vit ^a   Landova, Ludmila ^a   Syslova, Kamila ^c   Kuzma, Marek ^d   Kacer, Petr ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

^c INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^d INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

5 OHMeU; 8 iso PGF2 ; 8 OHdG; 8 OHG; Dioxin; EBC; HNE; Leukotrienes; MDA; NO Tyr; Oxidative stress; SPECT; Urine

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 8 ISOPROSTANE; GLUCOSE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; MALONALDEHYDE; TYROSINE;

ARTICLE; BLOOD LEVEL; BRAIN BLOOD FLOW; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NITROSATIVE STRESS; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; URINALYSIS;

EID: 84857411919     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aly HA, Domènech O (2009) Cytotoxicity and mitochondrial dysfunction of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in isolated rat hepatocytes. Toxicol Lett. 191: 79-87.
2. Chapman EA, Thomas PS, Yates DH (2010) Breath analysis in asbestos-related disorders: a review of the literature and potential future applications. J Breath Res. 4: 034001.
3. Devaraj S, Hirany SV, Burk RF, Jialal I (2001) Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes, Clin Chem. 47: 1974-1979. (Pubitemid 33010714)
4. Funk CD (2005) Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discovery. 4: 664-672.
5. Hassoun EA, Wilt SC, Devito MJ, Van Birgelen A, Alsharif NZ, Birnbaum LS, Stohs SJ (2008) Induction of oxidative stress in brain tissues of mice after subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.Toxicol Sci. 42: 23-27.
6. Hassoun EA, Al-Ghafri M, Abushaban A (2003) The role of antioxidant enzymes in TCDD-induced oxidative stress in various brain regions of rats after subchronic exposure. Free Rad Biol Med. 35: 1028-1036. (Pubitemid 37315696)
7. IARC (1997) Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans, IARC Monographs 69. Lyon, France: International Agency for Research on Cancer.
8. Ichinose T, Yajima Y, Nagashima M, Takenoshita S, Nagamachi Y, Sagai M (2004) Lung carcinogenesis and formation of 89-hydroxy-deoxyguanosine in mice by diesel exhaust particles. Carcinogenesis. 112: 666-671.
9. Kern PA, Fishman RB, Song W, Brown AD, Fonseca V (2002) The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adipocytes and liver. Toxicology. 171: 117-125. (Pubitemid 34142486)
10. Klingenberg R, Hansson GK (2009) Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J. 30: 2838-2844.
11. Kopf PG, Walker MK (2010) 2,3,7,8-tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1. Toxicol Appl Pharmacol. 245: 91-99.
12. Laufs U (2003) Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol. 58: 719-731.
13. Lin PH, Lin CH, Huang CC, Chuang MC, Lin P (2007) 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 172: 146-158. (Pubitemid 47189732)
14. Loukides S, Bakakos P, Kostikas K (2011) Oxidative Stress in Patients with COPD. Current Drug Targets. 12: 469-477.
15. Nedeljkovic ZS, Gokce N, Loscalzo J (2003) Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med. 79: 195-200. (Pubitemid 36605780)
16. Pelclová D, Fenclová Z, Dlasková Z, Urban P, Lukas E, Procházka B, et al (2001) Biochemical, neuropsychological, and neurological abnormalities following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. Arch Environ Health. 56: 493-500. (Pubitemid 34274972)
17. Pelclová D, Fenclová Z, Preiss J, Procházka B, Spáčil J, Dubská Z, et al (2002) Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-TCDD. Int Arch Occup Environ Health. 75 Suppl: 60-66.
18. Pelclová D, Fenclová Z, Urban P, Ridzoň P, Preiss J, Kupka K, Malík J, Dubská Z, Navrátil T (2009) Chronic health impairment due to 2,3,7,8-tetrachloro-dibenzo-p-dioxin exposure. Neuro Endocrinol Lett. 30 Suppl 1: 219-224.
19. Pelclová D, Prázný M, Škrha J, Fenclová Z, Kalousová M, Urban P, et al (2007) Vascular dysfunction induced by 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD). Hum Exp Toxicol. 26: 705-713.
20. Preiss J, Pelclová D, Fenclová Z, Urban P (2010) Neuropsychology and neurotoxicity in long-term monitoring of dioxin effects. Cesk Psychol. 54: 525-545.
21. Pelclová D, Fenclová Z, Kačer P, Kuzma M, Navrátil T, Lebedová J (2008) Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure. Ind Health. 46: 484-489.
22. Radi R (2004) Nitric oxide, oxidants, and protein tyrosine nitration. PNAS 101: 4003-4008.
23. Reichard JF, Dalton TP, Shertzer HG, Puga A (2006) Induction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptor. Dose Response. 3: 306-331.
24. Shertzer HG (2010) Protective effects of the antioxidant 4b,5,9b,10-tetrahydroindeno[1,2-b]indole against TCDD toxicity in C57BL/6J mice. Int J Toxicol. 29: 40-48.
25. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF Jr, Penn MS, Sprecher DL, Vita JA, Hazen SL (2003) Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA. 289: 1675-1680. (Pubitemid 37430273)
26. Syslová K, Kačer P, Kuzma M, Najmanová V, Fenclová Z, Vlčková S, Lebedová J, Pelclová D (2009) Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 877: 2477-2486.
27. Syslová K, Kačer P, Kuzma M, Pankrácová A, Fenclová Z, Vlčková S, Lebedová J, Pelclová D (2010) LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. J Breath Res. 4: 017104.
28. Syslová K, Kačer P, Vilhanová B, Kuzma M, Lipovová P, Fenclová Z, Lebedová J, Pelclová D (2011) Determination of cysteinyl leukotrienes in exhaled breath condensate: Method combining immunoseparation with LC-ESI-MS/MS, J Chromatogr. B, Analyt Technol Biomed Life Sci. 879: 2220-2228.
29. Urban P, Pelclová D, Lukáš E, Kupka K, Preiss J, Fenclová Z, Smerhovsky Z (2007) Neurological and neurophysiological follow-up of workers with chronic poisoning by 2,3,7,8-TCDD - 35 years after exposure. Eur J Neurol. 14: 213-218. (Pubitemid 46148311)
30. Yoshida R, Ogawa Y (2010) Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: an application of oxidative stress markers to cancer risk assessment of dioxins. Ind Health. 38: 5-14.